The United Arab Emirates Genomics Medicine and Biotechnology Paradigms

 

In recent days, the United Arab Emirates  (UAE) is drawing attention as one of the countries capable of taking the world global lead in genomic medicine and disease prevention. With the rapid expansion in Research and Development in Health Care, focused on adopting and implementing advanced techniques, the UAE is revolutionizing its healthcare system and doing everything in its power to set the standards that other nations will strive to achieve.

Her Excellency in Genomic Applications

Establishing such norms properly presents a considerable challenge. However, the example of the development of genomic medicine in the UAE suggests that it is indeed possible. One of the major contributing factors is the investment in breakthrough projects like the UAE Genome Program.

The Initiative aims at sequencing the genomes of the people of the country, producing the genetic information that will aid in genetic disorders diagnosis and treatment in record time. An approach to health care that enables the provision of medicinal therapeutic interventions to these men and women based on their DNA integrated into the healthcare system is referred to as genomics medicine. 

Extensive Public Health Policies

Furthermore, the UAE authorities have adopted modern health policies that also include genomic studies within popular health campaigns. These approaches are rooted in health promotion, concentrating mainly on detection and treatment of disease in its early stages. With this capabilities, the doctors will be able to stratify patients using their genomic profile, and design appropriate interventions, for instance, health education programs, curbing the rates of chronic illnesses and improving the health of the population.

Reach and Impact: The Role of Internationalization

The achievements of the UAE in the field of genomes medicine have no limits. Thanks to the initiation of such projects in the United Arab Emirates, the latter participates in the battle against hereditary disorders as part of the global community. It is within this framework that delegation of authority incurs new risks as health challenges can and often do outstrip local capacities.